Opko Health (OPK) Getting Positive News Coverage, Study Finds


04 July, 2017

Taking a broader look brokerage firms' analysts on the street with an expectant view have Opko Health Inc (NASDAQ:OPK) high price target of $19.5 and with a conservative view have low price target of $8.

On Friday, June 30th, Phillip Md Et Al Frost acquired 3,600 shares of Opko Health stock. Its Average True Range (ATR) value figured out at 6.30. The CEO now owns $1,077,815,212 of the stock according to the SEC filing. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. The business had revenue of $296.10 million during the quarter, compared to analyst estimates of $313.36 million. The stock was purchased at an average price of $6.97 per share, with a total value of $12,546.00. The stock was purchased at an average price of $6.43 per share, with a total value of $1,286,000.00. Over the last three months, insiders acquired 2,796,600 shares of company stock valued at $19,058,771. (OPK) have 564.48 million outstanding shares now held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders. The 200 SMA is considered so critically important a trend indicator that the event of the 50-day SMA crossing to the downside of the 200-day SMA is referred to as a death cross, signaling a serious bear market in a stock, index or other investment. The biotechnology company reported ($0.06) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.02. Phillip Md Et Al Frost, CEO disclosed the purchase of 1,800 shares of OPK stock. The company's market capitalization is $3.68 billion.

Traders are a little more bearish on Opko Health, Inc. recently as indicated by the motion in short interest.

There has been some buying insider activity on Opko Health, Inc.

03/03/2017 - Opko Health Inc had its "buy" rating reiterated by analysts at Standpoint Research. Opko Health, Inc. The stock's 50-day moving average is $6.59 and its 200-day moving average is $8.10. Equities research analysts expect that Opko Health will post ($0.20) earnings per share for the current year. The company generated a return on equity (ROE) of -2.10%. During the same quarter in the previous year, the firm earned ($0.02) EPS. World Asset Management Inc raised its position in shares of Opko Health by 23.6% in the first quarter. If you are viewing this story on another website, it was illegally copied and republished in violation of U.S. & worldwide copyright and trademark laws. The correct version of this article can be accessed at https://www.themarketsdaily.com/2017/07/03/phillip-md-et-al-frost-purchases-1800-shares-of-opko-health-inc-nasdaqopk-stock.html. Zacks Investment Research downgraded Opko Health from a "hold" rating to a "sell" rating in a research note on Thursday, May 4th. Private Advisor Group LLC now owns 49,521 shares of the biotechnology company's stock valued at $377,000 after buying an additional 10,670 shares during the period. Comerica Bank acquired a new position in shares of Opko Health during the fourth quarter valued at about $117,000.

Piedmont Investment Advisors LLC expanded its ownership by buying 102,063 shares an increase of 173.7% as of 03/31/2017. State Street Corp boosted its stake in shares of Opko Health by 40.3% in the first quarter. Over the past 2 quarters, the stock is down -42.58%, compared with a fall of almost -17.75% for 3 months and about 2.49% for the past 30 days. Opko Health's revenue for the quarter was up 1.8% on a year-over-year basis. As of quarter end Proficio Capital Partners LLC had disposed of a total of 524 shares trimming its stake by 84.8%. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also facilitate in determining where it may be possibly heading.

OPKO Health, Inc., launched on November 18, 1991, is a diversified healthcare company. The diagnostics segment primarily consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.

More news

  • Forward View Upgrades West Marine, Inc. (WMAR) to "Hold"

    One analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. After $-0.29 actual EPS reported by West Marine, Inc. for the previous quarter, Wall Street now forecasts -406.90% EPS growth.

    Credit Suisse Group (NYSE:CS) Broker Views On Wall Street

    Commonwealth Financial Services LLC boosted its position in shares of Credit Suisse Group by 2.6% in the first quarter. Edge Wealth Management LLC acquired a new position in Credit Suisse Group during the first quarter valued at $149,000.

    The Positive News Coverage Likely to Impact Intercontinental Exchange (ICE) Stock Price

    The stock of Intercontinental Exchange Inc (NYSE:ICE) has "Overweight" rating given on Tuesday, December 15 by Barclays Capital. In other news, Director Jean Marc Forneri sold 4,000 shares of the business's stock in a transaction on Thursday, June 8th.
  • Conservative MP pleads not guilty over false election expenses

    He beat Nigel Farage, the then leader of the Euroskeptic United Kingdom Independence Party (UKIP), in 2015 by 2,812 votes. The case comes after allegations of overspending by some Conservative candidates and their agents in the 2015 election.
    Kongolo leaves Feyenoord for Monaco in €15 million deal

    Kongolo leaves Feyenoord for Monaco in €15 million deal

    With 2 months remaining in the summer transfer window , the road is however long. "It's very important for us". And today Monaco completed the signing of Feyenoord defender Terence Kongolo in a £13.1m deal.

    Xerox Corporation (XRX) Given "Sell" Rating at Barclays PLC

    Moreover, Zurcher Kantonalbank (Zurich Cantonalbank) has 0.08% invested in Xerox Corp (NYSE:XRX) for 856,284 shares. Xerox Corporation (XRX ) has a market capitalization of 7.4 Billion while its Major Index membership is at S&P 500.
  • Meister's Corvex Said To Target Clariant In Bid To Derail Huntsman Merger

    The companies had targeted to complete the merger by the end of 2017, but this schedule remains subject to shareholder approval.
    Death toll in Mpumalanga bus, truck collision rises to 18

    Death toll in Mpumalanga bus, truck collision rises to 18

    "The remaining patients were transported by ambulance to various hospitals in the area for urgent treatment", Meiring confirmed. The minibus was reportedly transporting mine workers when the accident happened.
    Uber Should Be Regulated as Taxi Service, European Legal Adviser Says

    Uber Should Be Regulated as Taxi Service, European Legal Adviser Says

    Under EU law, national governments have a high degree of control over local transport regulation. Because France did not do so, Uber contended, the law could not be enforced.
  • Bank of America Corporation Downgrades California Resources Corporation (CRC) to Underperform

    The Company produced approximately 140 thousand barrels of oil equivalent per day (MBoe/d), as of December 31, 2016. Shares of California Resources Corporation (CRC ) touched the day high at $9.14 while its day Low was at $8.41.
    Mithali Raj has different plans against Sri Lanka

    Mithali Raj has different plans against Sri Lanka

    Mithali Raj said that the team will give stress on not losing wickets so early in their fourth match against Sri Lanka . She has led the team from the front as India sit on top of the points table with a win in every match.

    Comcast Corporation (CMCSA) Receives Average Rating of "Buy" from Brokerages

    The total number of shares percentage held by insiders is about 0.16% while the number of Shares % held by institutions is 84.6%. With 23,100 avg volume, 3 days are for Baldwin & Lyons Class B (NASDAQ:BWINB)'s short sellers to cover BWINB's short positions.